MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Phase 1
Recruiting
Conditions
Diabetes Mellitus
First Posted Date
2024-03-12
Last Posted Date
2024-03-27
Lead Sponsor
University of Chicago
Target Recruit Count
3
Registration Number
NCT06305286
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Phase 2
Not yet recruiting
Conditions
Triple Negative Breast Cancer
Interventions
First Posted Date
2024-03-04
Last Posted Date
2025-01-24
Lead Sponsor
University of Chicago
Target Recruit Count
85
Registration Number
NCT06291064

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

Phase 1
Recruiting
Conditions
Myeloproliferative Neoplasms
Interventions
First Posted Date
2024-03-04
Last Posted Date
2024-10-16
Lead Sponsor
University of Chicago
Target Recruit Count
18
Registration Number
NCT06291987
Locations
🇺🇸

University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Durometer for Measuring Uterine Tone

Not Applicable
Recruiting
Conditions
Uterine Tone Disorders
Cesarean Section Complications
Interventions
Device: Shore durometer
First Posted Date
2024-02-29
Last Posted Date
2025-05-06
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT06284421
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Efficacy Of Hiatal Closure For GERD

Recruiting
Conditions
Gastro Esophageal Reflux
First Posted Date
2024-02-28
Last Posted Date
2025-03-12
Lead Sponsor
University of Chicago
Target Recruit Count
40
Registration Number
NCT06280664
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Hypofractionation (Radiation) Trial for Multiple Myeloma

Phase 1
Recruiting
Conditions
Multiple Myeloma
Interventions
Radiation: Radiation
First Posted Date
2024-02-21
Last Posted Date
2025-02-06
Lead Sponsor
University of Chicago
Target Recruit Count
30
Registration Number
NCT06270888
Locations
🇺🇸

The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Nicotine Virtual Reality Conditioned Place Preference

Phase 4
Withdrawn
Conditions
Nicotine Use Disorder
Nicotine Addiction
Interventions
Drug: Placebo oral capsule
First Posted Date
2024-02-14
Last Posted Date
2024-02-14
Lead Sponsor
University of Chicago
Registration Number
NCT06259630
Locations
🇺🇸

University of Chicago Medical Center - Human Behavioral Pharmacology Lab, Chicago, Illinois, United States

Oxygenation in Vascular Lesions of the Colon

Not Applicable
Recruiting
Conditions
Vascular Lesion
Interventions
Other: Oxygen saturation
First Posted Date
2024-01-30
Last Posted Date
2024-05-08
Lead Sponsor
University of Chicago
Target Recruit Count
30
Registration Number
NCT06230731
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

A Novel Intervention for Weight Loss in Young Adults

Not Applicable
Recruiting
Conditions
Weight Loss
Interventions
Behavioral: Lifestyle II
Behavioral: Lifestyle
First Posted Date
2024-01-30
Last Posted Date
2024-07-18
Lead Sponsor
University of Chicago
Target Recruit Count
320
Registration Number
NCT06230744
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Percutaneous Nerve Evaluation Trial Time

Not Applicable
Recruiting
Conditions
Urge Incontinence
Urgency-frequency Syndrome
Overactive Bladder
Interventions
Procedure: Sacral neuromodulation
First Posted Date
2024-01-26
Last Posted Date
2025-01-27
Lead Sponsor
University of Chicago
Target Recruit Count
193
Registration Number
NCT06226220
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath